Discovery of recurrent structural variants in nasopharyngeal carcinoma

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 3.
Figure 3.

Validation of somatic structural breakpoints by PCR (images were inverted for better presentation). (A) Agarose gel of PCR products amplified from genomic DNA, targeting breakpoints detected by SMASH in NPC-5989. Because the breakpoints are somatic, specific PCR bands only occur in the tumor sample (pointed out by red arrows). (T) tumor sample; (N) matched normal sample from blood; (W) no-DNA control; (L) 1 kb plus ladder. (B) Agarose gel of PCR products amplified by RT-PCR on tumor RNA corresponding to somatic gene fusions in NPC-5989 and NPC-5421. RT primers were ∼200 bp downstream from the fusion points. PCR primers were within 150 bp upstream of and downstream from the fusion points to specifically amplify across it. (T) tumor; (C) control sample (different tumor); (L) 1 kb plus ladder. Specific products within the expected size range are pointed out by red arrows.

This Article

  1. Genome Res. 24: 300-309

Preprint Server